CONMED Corp (CNMD) Form 8-K — Jun 1, 2026
CONMED Corporation entered into a First Omnibus Amendment to its credit agreement on May 27, 2026, securing commitments for a new $450 million senior secured delayed draw term loan facility (Term A-2). The facility matures on June 10, 2030, and carries an initial interest rate margin of 1.75% over SOFR or 0.75% over the base rate, subject to adjustment based on leverage ratios. The proceeds from this new debt facility are designated for the repurchase of a portion of CONMED’s outstanding 2.25% Convertible Senior Notes due 2026, as well as to pay associated fees and expenses.
Key figures
- Debt Amount
- 450000000
- Interest Rate
- 1.75% over SOFR or 0.75% over Base Rate initially
- Maturity Date
- June 10, 2030
- Convertible notes coupon
- 2.25%
- Convertible notes maturity
- 2026
- Total convertible notes principal
- 800000000
Price after filing
Close on the filing date to close N calendar days later (from $34.65). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.